Request Sample Inquiry
Meningococcal Vaccines Market

Meningococcal Vaccines Market

Meningococcal Vaccines Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

200

Base Year:

2023

Date

Jun - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2489

Segments Covered
  • By Type By Type Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines
  • By Age Group By Age Group Infants (0 to 2 Years), Children & Adults (2 Years & Above)
  • By Serotype By Serotype Serotype A, Serotype B, Serotype C, Serotype W-135, Serotype Y
  • By Distribution Channel By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Others (Online Pharmacies, Drug Stores)
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 3.61 Billion
Revenue 2032Revenue 2032: USD 6.35 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 6.5%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Meningococcal Vaccines Market - Segment Analysis
    1. Overview
    2. Global Meningococcal Vaccines Market, 2016 - 2028 (USD Million)
    3. Global Meningococcal Vaccines Market - by Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    4. Global Meningococcal Vaccines Market - by Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    5. Global Meningococcal Vaccines Market - by Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    6. Global Meningococcal Vaccines Market - by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
    7. Global Meningococcal Vaccines Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    8. Market comparative analysis
  4. North America Meningococcal Vaccines Market - Segment Analysis
    1. Overview
    2. North America Meningococcal Vaccines Market, 2016 - 2028 (USD Million)
    3. North America Meningococcal Vaccines Market, by Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    4. North America Meningococcal Vaccines Market, by Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    5. North America Meningococcal Vaccines Market, by Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    6. North America Meningococcal Vaccines Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
    7. North America Meningococcal Vaccines Market, by Country
      1. U.S.
        1. U.S. Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. U.S. Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. U.S. Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. U.S. Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      2. Canada
        1. Canada Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. Canada Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. Canada Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. Canada Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      3. Mexico
        1. Mexico Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. Mexico Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. Mexico Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. Mexico Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
  5. Europe Meningococcal Vaccines Market - Segment Analysis
    1. Overview
    2. Europe Meningococcal Vaccines Market, 2016 - 2028 (USD Million)
    3. Europe Meningococcal Vaccines Market, by Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    4. Europe Meningococcal Vaccines Market, by Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    5. Europe Meningococcal Vaccines Market, by Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    6. Europe Meningococcal Vaccines Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
    7. Europe Meningococcal Vaccines Market, by Country
      1. Germany
        1. Germany Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. Germany Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. Germany Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. Germany Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      2. UK
        1. UK Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. UK Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. UK Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. UK Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      3. France
        1. France Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. France Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. France Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. France Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      4. Spain
        1. Spain Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. Spain Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. Spain Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. Spain Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      5. Italy
        1. Italy Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. Italy Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. Italy Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. Italy Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      6. BENELUX
        1. BENELUX Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. BENELUX Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. BENELUX Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. BENELUX Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      7. Rest of Europe
        1. Rest Of Europe Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. Rest Of Europe Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. Rest Of Europe Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. Rest Of Europe Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
  6. Asia Pacific Meningococcal Vaccines Market - Segment Analysis
    1. Overview
    2. Asia Pacific Meningococcal Vaccines Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Meningococcal Vaccines Market, by Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    4. Asia Pacific Meningococcal Vaccines Market, by Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    5. Asia Pacific Meningococcal Vaccines Market, by Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    6. Asia Pacific Meningococcal Vaccines Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
    7. Asia Pacific Meningococcal Vaccines Market, by Country
      1. China
        1. China Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. China Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. China Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. China Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      2. Japan
        1. Japan Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. Japan Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. Japan Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. Japan Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      3. India
        1. India Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. India Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. India Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. India Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      4. South Korea
        1. South Korea Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. South Korea Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. South Korea Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. South Korea Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      5. South East Asia
        1. South East Asia Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. South East Asia Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. South East Asia Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. South East Asia Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. Rest of Asia Pacific Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. Rest of Asia Pacific Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. Rest of Asia Pacific Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
  7. Latin America Meningococcal Vaccines Market - Segment Analysis
    1. Overview
    2. Latin America Meningococcal Vaccines Market, 2016 - 2028 (USD Million)
    3. Latin America Meningococcal Vaccines Market, by Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    4. Latin America Meningococcal Vaccines Market, by Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    5. Latin America Meningococcal Vaccines Market, by Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    6. Latin America Meningococcal Vaccines Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
    7. Latin America Meningococcal Vaccines Market, by Country
      1. Brazil
        1. Brazil Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. Brazil Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. Brazil Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. Brazil Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      2. Argentina
        1. Argentina Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. Argentina Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. Argentina Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. Argentina Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      3. Rest of Latin America
        1. Rest of Latin America Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. Rest of Latin America Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. Rest of Latin America Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. Rest of Latin America Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
  8. Middle East & Africa Meningococcal Vaccines Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Meningococcal Vaccines Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Meningococcal Vaccines Market, by Type
      1. By Polysaccharide Vaccines
      2. By Conjugate Vaccines
      3. By Combination Vaccines
    4. Middle East & Africa Meningococcal Vaccines Market, by Age Group
      1. By Infants (0 to 2 Years)
      2. By Children & Adults (2 Years & Above)
    5. Middle East & Africa Meningococcal Vaccines Market, by Serotype
      1. By Serotype A
      2. By Serotype B
      3. By Serotype C
      4. By Serotype W-135
      5. By Serotype Y
    6. Middle East & Africa Meningococcal Vaccines Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Others (Online Pharmacies, Drug Stores)
    7. Middle East & Africa Meningococcal Vaccines Market, by Country
      1. GCC Countries
        1. GCC Countries Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. GCC Countries Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. GCC Countries Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. GCC Countries Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      2. South Africa
        1. South Africa Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. South Africa Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. South Africa Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. South Africa Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Meningococcal Vaccines Market, By Type
          1. By Polysaccharide Vaccines
          2. By Conjugate Vaccines
          3. By Combination Vaccines
        2. Rest of Middle East & Africa Meningococcal Vaccines Market, By Age Group
          1. By Infants (0 to 2 Years)
          2. By Children & Adults (2 Years & Above)
        3. Rest of Middle East & Africa Meningococcal Vaccines Market, By Serotype
          1. By Serotype A
          2. By Serotype B
          3. By Serotype C
          4. By Serotype W-135
          5. By Serotype Y
        4. Rest of Middle East & Africa Meningococcal Vaccines Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Others (Online Pharmacies, Drug Stores)
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Merck & Co. Inc. (U.S.)
    2. Pfizer Inc. (U.S.)
    3. Serum Institute of India Pvt. Ltd. (India)
    4. Sanofi (France)
    5. GSK PLC (UK)
    6. Walvax Biotechnology Co. Ltd. (China)
    7. Novartis AG (Switzerland)
    8. Hualan Biological Engineering Inc. (China) Inc.pta Pharmaceuticals Limited (Bangladesh)
    9. Bio-Med (P) Limited (India)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question
  • The global Meningococcal Vaccines valued at USD 3.61 Billion in 2023 and is expected to reach USD 6.35 Billion in 2032 growing at a CAGR of 6.5%.

  • The prominent players in the market are Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Serum Institute of India Pvt. Ltd. (India), Sanofi (France), GSK PLC (UK), Walvax Biotechnology Co. Ltd. (China), Novartis AG (Switzerland), Hualan Biological Engineering Inc. (China), Incepta Pharmaceuticals Limited (Bangladesh), Bio-Med (P) Limited (India).

  • The market is project to grow at a CAGR of 6.5% between 2024 and 2032.

  • The driving factors of the Meningococcal Vaccines include

  • North America was the leading regional segment of the Meningococcal Vaccines in 2023.